About this trial
Prospective observational crossover study of 150 consenting adult patients who are undergoing chronic pain management. For insomnia treatment, each patient ingests prescribed doses of Lemborexant or Zopiclone or Clonidine on alternate nights. Each patient uses a special validated sleep diary to collect data including pain score, sleep score, sleep duration, sleep medication type, and adverse effects. Each patient completes the diary for 3 continuous weeks. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.
Eligibility criteria
Qualifiers
adult chronic pain patients
good treatment compliance
severe chronic insomnia
failure of non-pharmacologic sleep therapy
Disqualifiers
obstructive sleep apnoea
body mass index (BMI) ≥40
organ insufficiency
cognitive disorder
Trial design
Treatments tested in this trial
- Lemborexant